These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2657101)

  • 1. Proteaselike sequence in hepatitis B virus core antigen is not required for e antigen generation and may not be part of an aspartic acid-type protease.
    Nassal M; Galle PR; Schaller H
    J Virol; 1989 Jun; 63(6):2598-604. PubMed ID: 2657101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen.
    Okamoto H; Tsuda F; Akahane Y; Sugai Y; Yoshiba M; Moriyama K; Tanaka T; Miyakawa Y; Mayumi M
    J Virol; 1994 Dec; 68(12):8102-10. PubMed ID: 7966600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra- and extracellular distribution and immunochemical characterization of hepatitis B virus nucleocapsid proteins produced by a human hepatoma cell line transfected with cloned viral DNA.
    Ohori H; Matsuda K
    Virology; 1989 Jan; 168(1):40-7. PubMed ID: 2535906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F; Peterson D; Milich D
    Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between frequency of amino acid changes in core region of hepatitis B virus (HBV) and the presence of precore mutation in Japanese HBV carriers.
    Karasawa T; Shirasawa T; Okawa Y; Kuramoto A; Shimada N; Aizawa Y; Zeniya M; Toda G
    J Gastroenterol; 1997 Oct; 32(5):611-22. PubMed ID: 9349986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis of hepatitis B virus e antigen: directed mutagenesis of the putative aspartyl protease site.
    Jean-Jean O; Salhi S; Carlier D; Elie C; De Recondo AM; Rossignol JM
    J Virol; 1989 Dec; 63(12):5497-500. PubMed ID: 2685358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic self-cleavage of hepatitis B virus core protein may generate serum e antigen.
    Miller RH
    Science; 1987 May; 236(4802):722-5. PubMed ID: 3554507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of interferon alpha therapy on the catalytic domains of the polymerase gene and basal core promoter, precore and core regions of hepatitis B virus.
    Chen RY; Bowden S; Desmond PV; Dean J; Locarnini SA
    J Gastroenterol Hepatol; 2003 Jun; 18(6):630-7. PubMed ID: 12753143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants.
    Parekh S; Zoulim F; Ahn SH; Tsai A; Li J; Kawai S; Khan N; Trépo C; Wands J; Tong S
    J Virol; 2003 Jun; 77(12):6601-12. PubMed ID: 12767980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes.
    Hosono S; Tai PC; Wang W; Ambrose M; Hwang DG; Yuan TT; Peng BH; Yang CS; Lee CS; Shih C
    Virology; 1995 Sep; 212(1):151-62. PubMed ID: 7545853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of HBV genomes from patients with fulminant hepatitis.
    Sterneck M; Kalinina T; Günther S; Fischer L; Santantonio T; Greten H; Will H
    Hepatology; 1998 Nov; 28(5):1390-7. PubMed ID: 9794926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis.
    Hasegawa K; Huang J; Rogers SA; Blum HE; Liang TJ
    J Virol; 1994 Mar; 68(3):1651-9. PubMed ID: 8107226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-binding activity of hepatitis B e antigen polypeptide lacking the protaminelike sequence of nucleocapsid protein of human hepatitis B virus.
    Matsuda K; Satoh S; Ohori H
    J Virol; 1988 Sep; 62(9):3517-21. PubMed ID: 3404582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally occurring deletions/insertions in HBV core promoter tend to decrease in hepatitis B e antigen-positive chronic hepatitis B patients during antiviral therapy.
    Peng Y; Liu B; Hou J; Sun J; Hao R; Xiang K; Yan L; Zhang J; Zhuang H; Li T
    Antivir Ther; 2015; 20(6):623-32. PubMed ID: 25838313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of hepatitis B virus core protein expression and genome replication by a small upstream open reading frame and naturally occurring mutations in the precore region.
    Zong L; Qin Y; Jia H; Ye L; Wang Y; Zhang J; Wands JR; Tong S; Li J
    Virology; 2017 May; 505():155-161. PubMed ID: 28260621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoacceptors threonine 162 and serines 170 and 178 within the carboxyl-terminal RRRS/T motif of the hepatitis B virus core protein make multiple contributions to hepatitis B virus replication.
    Jung J; Hwang SG; Chwae YJ; Park S; Shin HJ; Kim K
    J Virol; 2014 Aug; 88(16):8754-67. PubMed ID: 24850741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients.
    Laras A; Koskinas J; Avgidis K; Hadziyannis SJ
    J Viral Hepat; 1998 Jul; 5(4):241-8. PubMed ID: 9751010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
    Günther S; Paulij W; Meisel H; Will H
    Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The secretory core protein of human hepatitis B virus is expressed on the cell surface.
    Schlicht HJ; Schaller H
    J Virol; 1989 Dec; 63(12):5399-404. PubMed ID: 2685356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.